Entities / Entity
Sutro Biopharma.
company
- Reports this week
- 0
- Active events
- 0
- Connections
- 11
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ daysNo events began in the chosen period. Widen it, or reset.
Around Sutro Biopharma this week
News at the entities that move Sutro Biopharma most-
Leerink partners Mentioned togetherMarketBeat provided stock average ratings while Leerink Partners upgraded and Barclays raised its price objective for Summit Therapeutics.Moves Sutro Biopharma
-
Nasdaq StructuralNasdaq is a brand that utilizes services provided by Lumen Technologies.Moves Sutro Biopharma
-
Citigroup Mentioned togetherCitigroup and Morgan Stanley provided price target and rating updates for Altria on November 4, 2026.Moves Sutro Biopharma
Connections
The 4 strongest of 11, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Tennessee Department of Treasury Transactional
The Tennessee Department of Treasury purchased a new position in Sutro Biopharma's stock.
-
Leerink partners Mentioned together
Leerink Partners provided a price objective for Sutro Biopharma.
-
Nasdaq Structural
Sutro Biopharma is formally listed on the Nasdaq stock exchange.
-
Citigroup Mentioned together
Citigroup provided an 'outperform' rating on Sutro Biopharma.